Improving the patient experience is a collective effort for all those involved in the clinical research space, but it doesn’t have to be burdensome. Here, we offer some suggestions on how to alleviate some of the challenges faced by sites – specifically surrounding eClinical technology.
At the writing of the blog post, we’re starting to witness the industry reach an inflection point when it comes to decentralized clinical trials (DCTs) and their implications for research teams. But our approach to providing eClinical technology at Crucial Data Solutions remains constant: equip researchers with the right tools so they can meet patients…
The rising number of decentralized trials and hybrid trials over the past few years has necessitated the use of televisit solutions for remote study conduct. But there are a number of benefits to virtual visits for both research professionals and study participants, which we begin to explore in this blog post.
The trends infiltrating the clinical research industry – wearable integrations, mobile apps, machine learning, and more – aren’t just exciting concepts. They’re made possible and are now being used in studies with today’s technology.
A new wave of interest in virtual trials has been generated by the coronavirus pandemic. But will the enthusiasm remain after the conclusion of the pandemic? In this post, we provide our perspective on why the virtual trial may be here to stay.
Making patient engagement more achievable will lead to more successful clinical trials. In this post, we detail four best practices in the TrialKit platform to help research teams reach optimal patient engagement.
With growing interest in virtual trials comes the need for technology to support it. Keep reading to learn how TrialKit’s inherent design is ideal for data collection and study management in the virtual trial space.
A newer technique to the industry, bring your own device is approached with apprehension. In this post, we’ve identified four misconceptions about BYOD and provided explanations on each.